We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
851
Ardelyx
ARDX
$1.25B
– –
-851,291
Closed -$6.45M
ARKG icon
852
ARK Genomic Revolution ETF
ARKG
$1.54B
– –
-8,740
Closed -$808K
ARKK icon
853
ARK Innovation ETF
ARKK
$5.74B
– –
-7,060
Closed -$923K
BCO icon
854
Brink's
BCO
$4.87B
– –
-18,982
Closed -$1.46M
BILI icon
855
Bilibili
BILI
$7.56B
– –
-143,950
Closed -$17.5M
BLNK icon
856
Blink Charging
BLNK
$74.1M
– –
-176,342
Closed -$7.26M
CATX icon
857
Perspective Therapeutics
CATX
$327M
– –
-3,488
Closed -$28K
COOP
858
DELISTED
Mr. Cooper
COOP
– –
-20,096
Closed -$664K
CRH icon
859
CRH
CRH
$69.1B
– –
-51,875
Closed -$2.64M
FANG icon
860
Diamondback Energy
FANG
$53.5B
– –
-6,752
Closed -$634K
FBIO icon
861
Fortress Biotech
FBIO
$113M
– –
-1,500
Closed -$80K
GDDY icon
862
GoDaddy
GDDY
$13.6B
– –
-41,063
Closed -$3.57M
HAIN icon
863
Hain Celestial
HAIN
$44.8M
– –
-80,083
Closed -$3.21M
ICAD
864
DELISTED
iCAD Inc
ICAD
– –
-17,332
Closed -$300K
IGMS
865
DELISTED
IGM Biosciences
IGMS
– –
-122,029
Closed -$10.2M
LAB icon
866
Standard BioTools
LAB
$311M
– –
-173,646
Closed -$1.07M
LI icon
867
Li Auto
LI
$13.8B
– –
-6,473
Closed -$226K
MNKD icon
868
MannKind Corp
MNKD
$1.21B
– –
-11,500
Closed -$63K
NTES icon
869
NetEase
NTES
$81.5B
– –
-38,150
Closed -$4.4M
NVCR icon
870
NovoCure
NVCR
$1.89B
$0 ﹤0.01%
3
– –
NWSA icon
871
News Corp Class A
NWSA
$15.3B
– –
-23,724
Closed -$611K
OGN icon
872
Organon & Co
OGN
$3.55B
– –
-51,274
Closed -$1.55M
PAAS icon
873
Pan American Silver
PAAS
$18.2B
– –
-89,600
Closed -$2.56M
PBW icon
874
Invesco WilderHill Clean Energy ETF
PBW
$394M
– –
-4,620
Closed -$431K
PCH
875
DELISTED
PotlatchDeltic
PCH
– –
-32,428
Closed -$1.72M
33 34
35
36 37

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.